25 May 2013
Keywords: pfizer, economic, study, says, sutent, cost, effective
Article | 22 September 2008
Results from an international study presented at the European Society for Medical Oncology, in Stockholm, Sweden, predict that Pfizer's Sutent
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 September 2008
24 May 2013
© 2013 thepharmaletter.com